Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07793383 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 3

Name: Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 3 — clinical trial record (NCT07793383)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot applicable

SponsorYale University

Started2026-08-17

View on ClinicalTrials.gov ↗

Trial flagged as At Risk

Primary completion moved at least 3 months later Oct 2026 → Feb 2027

See other at-risk trials from Yale University

Amendment history

2026-09-26

Recruitment opened

Trial started: 2026-08-17 (last estimated 2026-11)

2026-09-22

Primary completion pushed: 2026-10 → 2027-02

Completion pushed: 2026-10 → 2027-02

Yale University

487 trials monitored

See 35 trials at risk

This study is stage 2, round 3 of a larger study which refines and optimizes the EMBED clinical decision support (CDS) to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder. See NCT03658642

Trial Details

NCT Number	NCT07793383
Lead Sponsor	Yale University Collaborators: National Institute on Drug Abuse (NIDA)
Conditions	Opioid Abuse (Disorder), Clinical Decision Support
Enrollment	100 participants
Start Date	2026-08-17
Primary Completion	2027-02 (estimated)
Study Completion	2027-02 (estimated)
Updated on ClinicalTrials.gov	2026-09-25